News | October 01, 2014

Allegheny Health Network First to Install SenoClaire, New Breast Imaging Solution With 3-D Tomosynthesis Solution

October 1, 2014 — GE Healthcare announced Allegheny Health Network is the first center in the nation to install SenoClaire, the company’s new breast tomosynthesis solution, which was approved by the U.S. Food and Drug Administration (FDA) in September. SenoClaire uses a low-dose short X-ray sweep around the positioned breast with nine exposures acquired with a “step-and-shoot” method, removing the potential motion from the tube, helping to reduce blur and increase image sharpness.

“We are pleased to be working with GE Healthcare to provide women with a precise screening tool to help detect breast cancer,” said William Poller, MD., director of the division of breast imaging at Allegheny Health Network. “When cancer is identified and treated earlier, we know women have a better rate of survival.”

Allegheny Health Network’s new Health + Wellness Pavilion in Wexford, Pa., is the first site in the nation to install SenoClaire. In the coming months, SenoClaire will be installed in additional Allegheny Health Network sites, including Allegheny General Hospital, West Penn Hospital, Forbes Hospital and Allegheny Valley.

“SenoClaire marks a significant step forward in helping our clinicians detect breast cancer,” said David Parda, M.D., chair, Allegheny Health Network Cancer Institute. “At Allegheny Health Network, we provide our patients with the most effective ways to battle cancer from every possible angle, with innovative procedures, medicines and technology.”

A key challenge when performing screening mammography is keeping the radiation levels as low as possible. With SenoClaire, there is no increase in dose from a 2-D standard mammogram to a 3-D view, which means there is no increased radiation to patients during a SenoClaire breast exam.

SenoClaire is compatible with the Centricity PACS (picture archiving and communications system) with universal viewer and supports the DICOM (digital imaging and communications in medicine) standard that can be read by capable PACS vendors. When SenoClaire is combined with GE Healthcare’s Centricity PACS and Centricity Clinical Archive solution, clinicians have access to the patient’s longitudinal record, providing data that helps to enable better patient care.

“SenoClaire builds on our breast care continuum, which offers physicians and patients a comprehensive suite of solutions, from screening and diagnosis through treatment and monitoring,” said Catherine Tabaka, chief marketing officer, Detection and Guidance Solutions, GE Healthcare. “SenoClaire not only offers patients a new solution to help clinicians better detect breast cancer, but does so with low dose radiation and high image quality. This new generation technology, breast tomosynthesis, together with innovative solutions like contrast-enhanced spectral mammography, automated whole breast ultrasound, and molecular breast imaging will equip healthcare providers with a comprehensive set of tools that will help their patients across the entire breast care continuum.”

GE Healthcare currently has 180 units installed in Europe, Australia, Latin America, Southeast Asia and the Middle East. GE Healthcare is actively working on SenoClaire installations throughout 2014 and into 2015.

Related Content

Comparison of Screening Recommendations Supports Annual Mammography
News | Mammography | August 22, 2017
When to initiate screening for breast cancer, how often to screen, and how long to screen are questions that continue...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Radiotherapy Prior to Surgery Reduces Secondary Tumor Risk in Early-Stage Breast Cancer Patients
News | Radiation Therapy | July 24, 2017
Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation...
Kubtec Launches New Website For Digital Imaging and Irradiation Products
News | Digital Radiography (DR) | July 20, 2017
Kubtec announced the launch a new website focused on the applications of digital X-ray imaging and irradiation for...
Volpara Solutions to Showcase Volpara Enterprise DDP Software at AHRA 2017
News | Mammography | July 11, 2017
Volpara Solutions Inc. will showcase its new Volpara Enterprise DDP software at the Association for Medical Imaging...
Fujifilm Showcases Digital Radiography, Mammography Innovations at AHRA 2017
News | Digital Radiography (DR) | July 06, 2017
Fujifilm Medical Systems U.S.A. Inc. will present its comprehensive portfolio of digital radiography (DR) and...
Feature | Breast Density | July 05, 2017 | By Nancy M. Cappello, Ph.D.
Two decades of research on the masking risk of dense breast tissue by mammography screening is indisputable. As the...
Solis Mammography Ranks No. 19 in Dallas Business Journal’s Middle Market 50
News | Mammography | June 30, 2017
June 30, 2017 — Solis Mammography was named the 19th fastest-growing, middle-market company in North Texas by the
Overlay Init